Rede Wealth
ABBV icon

Rede Wealth’s AbbVie ABBV Stock Holding History

Rede Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$419K Sell
1,602
-65
-4% -$16.7K 0.14% 69
2026
Q2 		$420K Buy
1,667
+5
+0.3% +$1.08K 0.14% 74
2026
Q1 		$362K Buy
1,662
+4
+0.2% +$887 0.13% 75
2025
Q4 		$379K Sell
1,658
-6,870
-81% -$1.56M 0.13% 68
2025
Q3 		$1.97M Buy
8,528
+6,781
+388% +$1.38M 1.55% 14
2025
Q2 		$324K Sell
1,747
-12
-0.7% -$2.23K 0.12% 82
2025
Q1 		$368K Sell
1,759
-130
-7% -$25.3K 0.13% 74
2024
Q4 		$336K Buy
1,889
+33
+2% +$6.07K 0.13% 77
2024
Q3 		$366K Sell
1,856
-21
-1% -$3.92K 0.14% 71
2024
Q2 		$322K Buy
1,877
+6
+0.3% +$994 0.3% 73
2024
Q1 		$341K Buy
1,871
+226
+14% +$38.9K 0.14% 68
2023
Q4 		$255K Buy
1,645
+5
+0.3% +$729 0.12% 77
2023
Q3 		$244K Sell
1,640
-820
-33% -$120K 0.12% 71
2023
Q2 		$331K Buy
2,460
+29
+1% +$4.25K 0.16% 71
2023
Q1 		$387K Buy
2,431
+24
+1% +$3.67K 0.2% 64
2022
Q4 		$389K Sell
2,407
-86
-3% -$13.2K 0.21% 56
2022
Q3 		$335K Sell
2,493
-10
-0.4% -$1.44K 0.2% 65
2022
Q2 		$383K Buy
2,503
+1
+0% +$153 0.22% 62
2022
Q1 		$405K Hold
2,502
– – 0.19% 65
2021
Q4 		$339K Sell
2,502
-508
-17% -$60K 0.17% 78
2021
Q3 		$324K Buy
3,010
+514
+21% +$58.7K 0.17% 84
2021
Q2 		$252K Buy
2,496
+201
+9% +$22.6K 0.13% 95
2021
Q1 		$249K Buy
2,295
+273
+14% +$29.2K 0.14% 91
2020
Q4 		$218K Buy
+2,022
New +$194K 0.15% 87

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Rede Wealth's ABBV Position: Q3 2026 in Review

Rede Wealth reduced its AbbVie (ABBV) stake by 3.9% in Q3 2026, selling an estimated $16.7K and leaving 1,602 shares worth $419K. The position accounts for 0.14% of the portfolio, ranked #69.

Rede Wealth first reported a position in ABBV in Q4 2020 and has held it in 24 quarters since. The position peaked at $1.97M in Q3 2025. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Rede Wealth held 1,602 shares of AbbVie worth $419K as of Q3 2026.
  • Rede Wealth sold 65 AbbVie shares in Q3 2026, an estimated $16.7K.
  • AbbVie made up 0.14% of Rede Wealth's portfolio in Q3 2026, its #69 holding.
  • Rede Wealth first reported a position in AbbVie in Q4 2020 and has held it in 24 quarters since.
  • Rede Wealth's AbbVie position peaked at $1.97M in Q3 2025.
  • 1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Rede Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.